Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | -2.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | -2.62% | |||
| Cost of Revenue | -0.48% | 29.31% | |||
| Gross Profit | -0.48% | -27.64% | |||
| SG&A Expenses | -0.48% | -10.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.48% | 13.60% | |||
| Operating Income | -0.56% | -89.64% | |||
| Income Before Tax | -0.52% | -91.54% | |||
| Income Tax Expenses | 0.44% | -164.61% | |||
| Earnings from Continuing Operations | -0.47% | -74.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.64% | 73.71% | |||
| Net Income | -0.44% | -74.19% | |||
| EBIT | -0.56% | -89.64% | |||
| EBITDA | -0.48% | -44.32% | |||
| EPS Basic | 0.00% | -74.26% | |||
| Normalized Basic EPS | 0.00% | -96.00% | |||
| EPS Diluted | 0.00% | -74.26% | |||
| Normalized Diluted EPS | 0.00% | -96.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.00% | -0.96% | |||